Sort   by:  
 Page size 
UnknownOutcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative.
Not available
S-EPMC10578294 | biostudies-literature
UnknownTreatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.
Not available
S-EPMC12273612 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
UnknownPitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Not available
S-EPMC7217863 | biostudies-literature
UnknownApplication of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
Not available
S-EPMC7217941 | biostudies-literature
UnknownThe tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
Not available
S-EPMC8636568 | biostudies-literature
UnknownPlasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088 | biostudies-literature
UnknownEffect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
Not available
S-EPMC7556338 | biostudies-literature
UnknownDexamethasone in Hospitalized Patients with Covid-19.
Not available
S-EPMC7383595 | biostudies-literature
Sort   by:  
 Page size